J. Wolinsky

Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”

G. Comi, M. Rovaris, M. Filippi, 2001, Neurology.

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

F. Fazekas, L. Kappos, F. Barkhof, 2005, Neurology.

Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptides.

J. Wolinsky, M. McCarthy, A. Lovett, 1993, The Journal of general virology.

The long march to surrogates of meaningful clinical outcomes in MS trials

C. A. Beck, J. Wolinsky, J. Wolinsky, 2011, Neurology.

Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection.

R. Fisher, J. Wolinsky, A. Clark, 1983, Archives of neurology.